EcoDrugPlus

Transthyretin

Ensembl ID : ENSCDRG00005015690
Gene Symbol: TTR
3 Cross references
166 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSCDRG00005013726
Gene Symbol: TPH1
3 Cross references
257 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSCDRG00005000805
Gene Symbol: TUBA4A
3 Cross references
225 Possible Orthologues:

Tubulin Beta 1 Class Vi

Ensembl ID : ENSCDRG00005019625
Gene Symbol: TUBB1
3 Cross references
186 Possible Orthologues:

Tubulin Beta 2b Class Iib

Ensembl ID : ENSCDRG00005015474
Gene Symbol: TUBB2B
1 Cross references
224 Possible Orthologues:

Tubulin Beta 4a Class Iva

Ensembl ID : ENSCDRG00005021940
Gene Symbol: TUBB4A
1 Cross references
90 Possible Orthologues:

Tubulin Beta 4b Class Ivb

Ensembl ID : ENSCDRG00005022239
Gene Symbol: TUBB4B
1 Cross references
178 Possible Orthologues:

Tubulin Beta 6 Class V

Ensembl ID : ENSCDRG00005020468
Gene Symbol: TUBB6
1 Cross references
141 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSCDRG00005009237
Gene Symbol: TP53
3 Cross references
254 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSCDRG00005009674
Gene Symbol: TYR
1 Cross references
266 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSCDRG00005020996
Gene Symbol: TH
1 Cross references
188 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSCDRG00005007070
Gene Symbol: TYK2
1 Cross references
197 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).